Display Settings:

Format

Send to:

Choose Destination

    Mini Rev Med Chem. 2009 Aug;9(9):1052-63.

    The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.

    Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R.

    Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, 53100 Siena, Italy. gennari@unisi.it

    Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally abnormal bone, deformity and other complications leading to significant disability and bone pain. Recently, the availability of newer, more potent nitrogen-containing bisphosphonates has improved treatment outcomes, allowing a more effective and convenient management of this disorder.

    PMID: 19689402 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Pamidronate Injection (Aredia®)

      Pamidronate is used to treat high levels of calcium in the blood that may be caused by certain types of cancer. Pamidronate is also used along with cancer chemotherapy to treat bone damage caused by multiple myeloma (can...

    • Zoledronic Acid Injection (Reclast®, Zometa®)

      Zoledronic acid (Reclast) is used to treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause ('change of life,' end of regular menstrual periods). Zol...